Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide

Hypertension

Volumn 30, Issue 1, 1997, Pages 83-87

  Mukaddam Daher, Suhayla ^b   Lambert, Chantal ^b   Gutkowska, Jolanta ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

Atrial natriuretic factor; Clonidine; Imidazoles; Receptors, adrenergic, alpha; Yohimbine

Indexed keywords

2 (2,6 DIETHYLANILINO) 2 IMIDAZOLINE; ATRIAL NATRIURETIC FACTOR; CLONIDINE; IMIDAZOLINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; FEMALE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030803537     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.83     Document Type: Article

References (25)

1. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol. 1987;81:39-100.
2. Michel MC, Insel PA. Are there multiple imidazoline binding sites? Trends Pharmacol Sci. 1989;10:342-344.
3. Molderings GJ, Hentrich F, Gothert M. Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:630-638.
4. Ersenberger P, Graves M, Graff L, Zakieh N, Nguyen P, Collins L, Westbrooks K, Johnson G. I1-Imidazoline receptors: definition, characterization, distribution, and trans-membrane signaling. Ann NY Acad Sci. 1995;763:22-42.
5. Wang H, Regunathan S, Meeley MP, Reis DJ. Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol Pharmacol. 1992;42:792-801.
6. Limon I, Coupry I, Tesson F, Lachaud-Pettiti V, Parini A. Renal imidazoline-guanidinium receptive site: a potential target for anti-hypertensive drugs. J Cardiovasc Pharmacol. 1992;20:21-23.
7. Baranowska B, Tremblay J, Gutkowska J. Clonidine stimulates atrial natriuretic factor (ANF) release in water-deprived rats. Peptides. 1988;9(suppl 1):189-192.
8. Gutkowska J, Mukaddam-Daher S, Tremblay J. The peripheral action of clonidine analogue ST-91: involvement of atrial natriuretic factor. J Pharmacol Exp Ther. In press.
9. Kobinger W, Pichler L. Investigation into some imidazoline compounds with respect to peripheral alpha adrenoceptor stimulation and depression of cardiovascular centers. Naunyn Schmiedebergs Arch Pharmacol. 1975;292:175-191.
10. Lambert C, Mossiat C, Tanniere-Zeller M, Maupoil V, Rochette L. Antiarrhythmic effect of amiodarone on doxorubicin acute toxicity in working rat hearts. Cardiovasc Res. 1990;24:653-658.
11. Gutkowska J. Radioimmunoassay for atrial natriuretic factor. Nucl Med Biol. 1987;14:323-331.
12. Ohara-Imaizumi M, Kumakura K. Effects of imidazoline compounds on catecholamine release in adrenal chromaffin cells. Cell Mol Neurobiol. 1992;12:273-283.
13. Atlas D, Diamant S, Zonnenschein R. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity. Am J Hypertens. 1992;5:83S-90S.
14. Dontenwill M, Tibrica E, Greney H, Bennai F, Feldman J, Stutzmann J, Bricca G, Belcourt A, Bousquet P. Role of imidazoline receptors in cardiovascular regulation. Am J Cardiol. 1994;74: 3A-6A.
15. Ernsberger P, Guilliano R, Willette RN, Reis DJ. Role of imidazole receptors in the vaso-depressor response to clonidine analogues in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 1990;253: 408-418.
16. 2 adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn Schmiedebergs Arch Pharmacol. 1991;343:271-282.
17. Atlas D, Burnstein Y. Isolation and partial purification of clonidine displacing endogenous brain substance. Eur J Pharmacol. 1984;144: 287-293.
18. 2-adrenoceptors and putative imidazoline receptors on rabbit heart sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1993;348:127-133.
19. Meeley MP, Ernsberger PR, Granata AR, Reis DJ. An endogenous clonidine displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 1986; 38:1119-1126.
20. Li G, Regunathan S, Barrow C, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine displacing substance in the brain. Science. 1994;263:966-969.
21. Raasch W, Regunathan S, Li G, Reis DJ. Agmatine is widely and unequally distributed in rat organs. Ann NY Acad Sci. 1995;763: 330-334.
22. 3H idazoxan-labeled non-adrenergic sites in rabbit white fat cells. Eur J Pharmacol. 1990;188:261-272.
23. Shams G, Venkataraman B, Hamada A, Miller DD, Patil PN, Feller DR. Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta. Eur J Pharmacol. 1991;199:315-323.
24. Laubie M, Schmitt H. Sites of action of clonidine: centrally mediated increase in vagal tone, centrally mediated hypotensive and sympatho-inhibitory effects. Prog Brain Res. 1977;47:337-348.
25. Atchison DJ, Ackermann U. The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J Auton Nerv Syst. 1993;42:81-88.